Jazz Pharmaceuticals plc
JAZZ· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Revenue | $309.30M | $246.92M | $196.24M | $102.53M |
| Net Income | $70.70M | -$92.65M | $43.43M | $27.68M |
| EPS Diluted | $1.12 |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| -$1.58 |
| $0.71 |
| $0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.